1 Spam-Free Article(s) Found
https://seekingalpha.com/news/4084596-lixte-stock-soars-on-preclinical-data-for-lead-drug-lb-100?source=feed_sector_healthcare
Mar 27, 2024 - Lixte (LIXT) stock was up nearly 60% Wednesday after the company reported the publication of positive preclinical data for its lead clinical asset LB-100. Read more here.
0
sa:-2623239324165946515
0